New regulation simplifies registration and expands the use of biodiversity in herbal medicines, as soon as cannabis products are classified as medicines, they must comply with these standards.

Debates on medicinal cannabis continue deeply at Cannabis Connection 2025 in November and at the Brazilian Medicinal Cannabis Congress in May 2026, both in São Paulo.

Initiative complies with State Law 8,754/22 and aims to prepare professionals to prescribe cannabis safely and legally

Learn How to Access Cannabis Products Through the Unified Health System and Understand the Obligations of Health Insurance Providers

Hemp is making its way into makeup with promises of natural beauty, but still faces challenges in regulation and skin science

COFFITO Ruling No. 735/2024 authorizes physical therapists with specific training to prescribe medications and supplies; however, Anvisa recognizes only doctors and dentists as prescribers of cannabis for medicinal purposes

Paula Scanapieco, a specialist in medical cannabis logistics, speaks on Deusa Cast about the importance of RDC 660, product quality, and the role of companies in providing reliable information to doctors and patients in Brazil

Follow the instructions to initiate the import process through RDC 660

Anvisa points out the USA as the main supplier, followed by Canada, Colombia, and Uruguay

D9Tech consolidates itself as the technological infrastructure driving the growth of the medical cannabis market in Brazil, offering integrated solutions in management, payments, and health with a focus on efficiency, security, and governance

The agency determined the suspension of the commercialization and advertising of all items from the brands Golden CBD Plus and Golden CBD+ Nanotech in the national territory.

Discover in Sechat 2024's free e-book how medical cannabis is revolutionizing dentistry, offering pain relief, inflammation control, and well-being during treatments.

Companies report delays in shipments clearance, while official data from Anvisa indicate reduced average deadlines and high approval rates

Discover what medical cannabis is, what it's for, and how this treatment has been advancing in Brazil, with proven benefits and safe medical guidance

New US rule restricts hemp derivatives and opens opportunity for South American countries to meet part of the Brazilian demand

End of the Farm Bill shutdown in the US exposes Brazil's vulnerability due to lack of cultivation and lack of productive autonomy to ensure self-sufficiency

American measure rendering full spectrum extracts unfeasible has a long transition period, but already positions Uruguay as a new strategic export alternative

New authorization expands university's scope in Reblas and reinforces quality control of plant derivatives in the national market

Regulatory agency bans commercialization and advertising of items from the brands due to lack of sanitary authorization; understand the decision and the companies' positions

Anvisa authorizations for importing cannabidiol in São Paulo increased by 6.2% between January and July 2025, consolidating the state as a leader in requests and reflecting the expanded access through the SUS